Is Ligand Pharmaceuticals Incorporated (LGND) a Buy, Sell, or Hold?
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
$300.97 USD
-$8.28 (-2.68%)
- Volume
- 649.08K
- Average Volume
- 331.69K
- Market Capitalization
- $6.03B
- P/E Ratio
- 38.39
- Dividend Yield
- 0.00%
- Price Target
- $289.00
- Year High
- $326.63
- Year Low
- $122.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.28
Analyst Rating
Neutral
3 Rating Score
UPSIDE/DOWNSIDE
4.1% UPSIDE
$289.00 Price Target
UPSIDE/DOWNSIDE HIGH
-9.3% DOWNSIDE
$332.00 Price Target High
UPSIDE/DOWNSIDE LOW
19.4% UPSIDE
$252.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Annabel Samimy | $332 | $319.43 | 2026-07-08 07:06 AM | 3.9% |
| H.C. Wainwright | Joseph Pantginis | $289 | $224.86 | 2026-04-30 06:09 AM | 28.5% |
| H.C. Wainwright | Joseph Pantginis | $243 | $231.11 | 2026-04-14 10:43 AM | 5.1% |
| H.C. Wainwright | Joseph Pantginis | $239 | $190.8609 | 2026-02-24 11:31 AM | 25.2% |
| Oppenheimer | Trevor Allred | $275 | $185.83 | 2025-12-10 06:54 AM | 48.0% |
| Stifel Nicolaus | Annabel Samimy | $220 | $208.22 | 2025-11-06 03:07 PM | 5.7% |